Deal of the Day — limited-time pharmacy picks!
Odensomab 60mg Injection

Odensomab 60mg Injection

Prescription requiredRx Required

Salt Composition: Denosumab

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

1 Prefilled Syringe(s)

About The Product

Bone disease

Odensomab 60mg Injection contains Denosumab as an active ingredient that is a monoclonal antibody. Doctor prescribes it to treat osteoporosis in postmenopausal women and in men at increased risk of fractures. It makes the bones strong as well as reduces the risk of fractures.

It works by binding to a protein that causes bone loss, thereby strengthening the bone and minimizing the risk of fractures. It should be given by healthcare professional only do not self administer this injection.


Uses

Osteoporosis

Side Effects

Every medicine has some side effects that manage on their own as your body gets used to the medicine, but some people may rarely experience severe side effects. In that case, the patient should contact the doctor immediately.

Some common side effects of Odensomab 60mg Injection include:

  • Rash
  • Musculoskeletal (bone, muscle or joint) pain
  • Eczema
  • Upper respiratory tract infection
  • Sciatica
  • Pain in extremities
  • Back pain
  • Joint pain
  • Urinary tract infection
  • Constipation
  • Abdominal discomfort
  • Hair loss
  • Hypercholesterolemia (high cholesterol)
  • Cystitis
  • Nerve pain
  • Headache

How To Use

  • Odensomab 60mg Injection is a powerful monoclonal antibody that can only be given by a doctor or nurse under strict medical supervision.
  • It is not self-administrable.
  • Dosage and duration of the treatment are determined by the doctor as per the patient's health condition and type of the disease.

How It Works

Odensomab 60mg Injection contains Denosumab as an active ingredient that is a monoclonal antibody. It makes the bones strong as well as reduces the risk of fractures.

It works by binding to a protein that causes bone loss, thereby strengthening the bone and minimizing the risk of fractures.

Safety Advice

Alcohol
Avoid the consumption of alcohol while taking Odensomab 60mg Injection, as alcohol can reduce the effectiveness of the medicine and worsen the symptoms
Pregnancy
Do not take the Odensomab 60mg Injection without consulting the doctor in case of pregnancy, as it is an unsafe medicine during this period.
Breast Feeding
Breastfeeding women should discuss the potential risks and benefits of the Odensomab 60mg Injection with their healthcare provider before starting treatment
Driving
Odensomab 60mg Injection is usually consider safe in case of driving as it does not affect your ability to drive.
Kidney
Consumption of Odensomab 60mg Injection should be avoided without informing the doctor if you have any kidney-related issues.
Liver
Consumption of Odensomab 60mg Injection should be avoided without informing the doctor if you have any liver-related issues.

FAQs

There are some common yet manageable side effects of taking Odensomab Injection that include pain in extremities, back pain, joint pain, urinary tract infection, constipation, etc.

References

  • Burkiewicz, J. S., Scarpace, S. L., & Bruce, S. P. (2009). Denosumab in osteoporosis and oncology. Annals of Pharmacotherapy, 43(9), 1445-1455 - https://pubmed.ncbi.nlm.nih.gov/19622756/
  • Miyazaki, T., Tokimura, F., & Tanaka, S. (2014). A review of denosumab for the treatment of osteoporosis. Patient preference and adherence, 463-471 - https://pmc.ncbi.nlm.nih.gov/articles/PMC3986336/
  • Cummings, S. R., Martin, J. S., McClung, M. R., Siris, E. S., Eastell, R., Reid, I. R., ... & Christiansen, C. (2009). Denosumab for prevention of fractures in postmenopausal women with osteoporosis. New England Journal of Medicine, 361(8), 756-765 - https://pubmed.ncbi.nlm.nih.gov/19671655/
  • Deeks, E. D. (2018). Denosumab: a review in postmenopausal osteoporosis. Drugs & aging, 35(2), 163-173 - https://pubmed.ncbi.nlm.nih.gov/29435849/
  • Kendler, D. L., Cosman, F., Stad, R. K., & Ferrari, S. (2022). Denosumab in the treatment of osteoporosis: 10 years later: a narrative review. Advances in therapy, 39(1), 58-74 - https://pubmed.ncbi.nlm.nih.gov/34762286/
  • Zaheer, S., LeBoff, M., & Lewiecki, E. M. (2015). Denosumab for the treatment of osteoporosis. Expert opinion on drug metabolism & toxicology, 11(3), 461-470. - https://pubmed.ncbi.nlm.nih.gov/25614274/

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026